The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection

Reviews in Medical Virology

Volumn 21, Issue 5, 2011, Pages 315-329

  Martin Vilchez, Samuel ^a,c   Lara Pezzi, Enrique ^b   Trapero Marugán, Maria ^a,c   Moreno Otero, Ricardo ^a,c   Sanz Cameno, Paloma ^a,c,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Asociacion Espanola Contra el Cancer   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HEPATITIS B VIRUS X PROTEIN; PROTEASOME; REGULATOR PROTEIN; TRANSACTIVATOR PROTEIN;

ANGIOGENESIS; APOPTOSIS; CELL CYCLE; DNA VIRUS; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; LIFE CYCLE; LIVER CARCINOMA; LIVER FIBROSIS; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; FIBROSIS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; VIROLOGY;

FIBROSIS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; VIRUS REPLICATION;

EID: 80051925892     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.699     Document Type: Review

References (142)

1. Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. American Journal of Pathology 2000; 156: 1117-1132.
2. Seeger C, Mason WS, Zoulim F. Hepadnaviruses. Lippincott Williams & Wilkins: Philadelphia, PA, 2007.
3. Dejean A, Sonigo P, Wain-Hobson S, et al. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proceedings of the National Academy of Sciences of the United States of America 1984; 81: 5350-5354. Web of Science.
4. Seeger C, Mason WS. Hepatitis B virus biology. Microbiology and Molecular Biology Reviews 2000; 64: 51-68. Web of Science.
5. Beck J, Nassal M. Hepatitis B virus replication. World Journal of Gastroenterology 2007; 13: 48-64. Web of Science.
6. Wang GH, Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 1992; 71: 663-670. Web of Science.
7. Weber M, Bronsema V, Bartos H, et al. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. Journal of Virology 1994; 68: 2994-2999. Web of Science.
8. Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. Journal of Virology 1994; 68: 6-13. Web of Science.
9. Bartenschlager R, Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO Journal 1992; 11: 3413-3420. Web of Science.
10. Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004; 25: 2023-2032. Web of Science.
11. Murakami S. Hepatitis B virus X protein: structure, function and biology. Intervirology 1999; 42: 81-99. Web of Science.
12. Rui E, Moura PR, Goncalves K de A, et al. Expression and spectroscopic analysis of a mutant hepatitis B virus onco-protein HBx without cysteine residues. Journal of Virological Methods 2005; 126: 65-74. Web of Science.
13. Kumar V, Sarkar DP. Hepatitis B Virus X Protein (HBx): Structure-Function Relationships and Role in Viral Pathogenesis. Springer-Verlag: Berlin, 2004.
14. Kumar V, Jayasuryan N, Kumar R. A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 5647-5652. Web of Science.
15. Takada S, Koike K. Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins. Virology 1994; 205: 503-510. Web of Science.
16. Murakami S, Cheong JH, Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. Journal of Biological Chemistry 1994; 269: 15118-15123. Web of Science.
17. Schek N, Bartenschlager R, Kuhn C, et al. Phosphorylation and rapid turnover of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 1991; 6: 1735-1744. Web of Science.
18. Doria M, Klein N, Lucito R, et al. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO Journal 1995; 14: 4747-4757. Web of Science.
19. Henkler F, Hoare J, Waseem N, et al. Intracellular localization of the hepatitis B virus HBx protein. Journal of General Virology 2001; 82: 871-882. Web of Science.
20. Hoare J, Henkler F, Dowling JJ, et al. Subcellular localisation of the X protein in HBV infected hepatocytes. Journal of Medical Virology 2001; 64: 419-426. Web of Science.
21. Sirma H, Weil R, Rosmorduc O, et al. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome. Oncogene 1998; 16: 2051-2063. Web of Science.
22. Lee YI, Kim SO, Kwon HJ, et al. Phosphorylation of purified recombinant hepatitis B virus-X protein by mitogen-activated protein kinase and protein kinase C in vitro. Journal of Virological Methods 2001; 95: 1-10. Web of Science.
23. Hohne M, Schaefer S, Seifer M, et al. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO Journal 1990; 9: 1137-1145. Web of Science.
24. Siddiqui A, Jameel S, Mapoles J. Expression of the hepatitis B virus X gene in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 2513-2517. Web of Science.
25. Cha MY, Ryu DK, Jung HS, et al. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. Journal of General Virology 2009; 90: 978-986. Web of Science.
26. Keasler VV, Hodgson AJ, Madden CR, et al. Hepatitis B virus HBx protein localized to the nucleus restores HBx-deficient virus replication in HepG2 cells and in vivo in hydrodynamically-injected mice. Virology 2009; 390: 122-129. Web of Science.
27. Forgues M, Marrogi AJ, Spillare EA, et al. Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway. Journal of Biological Chemistry 2001; 276: 22797-22803. Web of Science.
28. Weil R, Sirma H, Giannini C, et al. Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Molecular and Cellular Biology 1999; 19: 6345-6354. Web of Science.
29. Tang H, Delgermaa L, Huang F, et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. Journal of Virology 2005; 79: 5548-5556. Web of Science.
30. Benhenda S, Cougot D, Buendia MA, et al. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Advances in Cancer Research 2009; 103: 75-109. Web of Science.
31. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. Journal of Virology 2004; 78: 12725-12734. Web of Science.
32. Faktor O, Shaul Y. The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax. Oncogene 1990; 5: 867-872. Web of Science.
33. Cheong JH, Yi M, Lin Y, et al. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO Journal 1995; 14: 143-150. Web of Science.
34. Haviv I, Shamay M, Doitsh G, et al. Hepatitis B virus pX targets TFIIB in transcription coactivation. Molecular and Cellular Biology 1998; 18: 1562-1569. Web of Science.
35. Barnabas S, Andrisani OM. Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression. Journal of Virology 2000; 74: 83-90. Web of Science.
36. Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007; 132: 1955-1967. Web of Science.
37. Lara-Pezzi E, Armesilla AL, Majano PL, et al. The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway. EMBO Journal 1998; 17: 7066-7077. Web of Science.
38. Lee DK, Park SH, Yi Y, et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes & Development 2001; 15: 455-466. Web of Science.
39. Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991; 252: 842-844. Web of Science.
40. Seto E, Mitchell PJ, Yen TS. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 1990; 344: 72-74. Web of Science.
41. Cougot D, Wu Y, Cairo S, et al. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. Journal of Biological Chemistry 2007; 282: 4277-4287. Web of Science.
42. Abramovitch R, Tavor E, Jacob-Hirsch J, et al. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression. Cancer Research 2004; 64: 1338-1346. Web of Science.
43. Tacke F, Liedtke C, Bocklage S, et al. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 2005; 54: 1309-1317. Web of Science.
44. Lucito R, Schneider RJ. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. Journal of Virology 1992; 66: 983-991. Web of Science.
45. Murakami S, Cheong J, Ohno S, et al. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 1994; 199: 243-246. Web of Science.
46. Su F, Schneider RJ. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. Journal of Virology 1996; 70: 4558-4566. Web of Science.
47. Benn J, Su F, Doria M, et al. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. Journal of Virology 1996; 70: 4978-4985. Web of Science.
48. Tarn C, Lee S, Hu Y, et al. Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. Journal of Biological Chemistry 2001; 276: 34671-34680. Web of Science.
49. Tarn C, Zou L, Hullinger RL, et al. Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. Journal of Virology 2002; 76: 9763-9772. Web of Science.
50. Klein NP, Schneider RJ. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Molecular and Cellular Biology 1997; 17: 6427-6436. Web of Science.
51. Bouchard MJ, Wang L, Schneider RJ. Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. Journal of Virology 2006; 80: 4406-4414. Web of Science.
52. Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 2001; 294: 2376-2378. Web of Science.
53. Bouchard MJ, Puro RJ, Wang L, et al. Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. Journal of Virology 2003; 77: 7713-7719. Web of Science.
54. Clippinger AJ, Bouchard MJ. Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. Journal of Virology 2008; 82: 6798-6811. Web of Science.
55. McClain SL, Clippinger AJ, Lizzano R, et al. Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels. Journal of Virology 2007; 81: 12061-12065. Web of Science.
56. Shirakata Y, Koike K. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. Journal of Biological Chemistry 2003; 278: 22071-22078. Web of Science.
57. Lara-Pezzi E, Roche S, Andrisani OM, et al. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. Oncogene 2001; 20: 3323-3331. Web of Science.
58. Tang H, Oishi N, Kaneko S, et al. Molecular functions and biological roles of hepatitis B virus x protein. Cancer Science 2006; 97: 977-983. Web of Science.
59. Blum HE, Zhang ZS, Galun E, et al. Hepatitis B virus X protein is not central to the viral life cycle in vitro. Journal of Virology 1992; 66: 1223-1227. Web of Science.
60. Belloni L, Pollicino T, De Nicola F, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 19975-19979.
61. Chen HS, Kaneko S, Girones R, et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. Journal of Virology 1993; 67: 1218-1226.
62. Zhang Z, Torii N, Hu Z, et al. X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. The Journal of Clinical Investigation 2001; 108: 1523-1531.
63. Xu Z, Yen TS, Wu L, et al. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. Journal of Virology 2002; 76: 2579-2584.
64. Tsuge M, Hiraga N, Akiyama R et al. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice. Journal of General Virology 2010; 91: 1854-1864.
65. Lucifora J, Arzberger S, Durantel D, et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. Journal of Hepatology 2011; DOI: 10.1016/j.jhep.2011.02.015.
66. Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 11215-11219.
67. Bouchard M, Giannakopoulos S, Wang EH, et al. Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. Journal of Virology 2001; 75: 4247-4257.
68. Chin R, Earnest-Silveira L, Koeberlein B, et al. Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis. Journal of Hepatology 2007; 47: 325-337.
69. Han HJ, Jung EY, Lee WJ, et al. Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Letters 2002; 518: 169-172.
70. Leach JK, Qiao L, Fang Y, et al. Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3. Journal of Gastroenterology and Hepatology 2003; 18: 376-385.
71. Mukherji A, Janbandhu VC, Kumar V. HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1. Biochemical Journal 2007; 401: 247-256.
72. Park SG, Chung C, Kang H, et al. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. Journal of Biological Chemistry 2006; 281: 31770-31777.
73. Qiao L, Leach K, McKinstry R, et al. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology 2001; 34: 906-917.
74. Gearhart TL, Bouchard MJ. The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. Journal of Virology 2010; 84: 2675-2686.
75. Hodgson AJ, Keasler VV, Slagle BL. Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Research 2008; 68: 10341-10348.
76. Fujii R, Zhu C, Wen Y, et al. HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Research 2006; 66: 9099-9107.
77. Kim S, Park SY, Yong H, et al. HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 2008; 27: 3457-3464.
78. Rakotomalala L, Studach L, Wang WH, et al. Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. Journal of Biological Chemistry 2008; 283: 28729-28740.
79. Wen Y, Golubkov VS, Strongin AY, et al. Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. Journal of Biological Chemistry 2008; 283: 2793-2803.
80. Yun C, Cho H, Kim SJ, et al. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway. Molecular Cancer Research 2004; 2: 159-169.
81. Pan J, Duan LX, Sun BS, et al. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. Journal of General Virology 2001; 82: 171-182.
82. Martin-Lluesma S, Schaeffer C, Robert EI, et al. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008; 48: 1467-1476.
83. Molina-Jimenez F, Benedicto I, Murata M, et al. Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation. Hepatology 2010; 51: 777-787.
84. Yu R, Lu W, Chen J, et al. Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology 2003; 144: 4991-4998.
85. Diao J, Khine AA, Sarangi F, et al. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. Journal of Biological Chemistry 2001; 276: 8328-8340.
86. Shih WL, Kuo ML, Chuang SE, et al. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. Journal of Biological Chemistry 2000; 275: 25858-25864.
87. Elmore LW, Hancock AR, Chang SF, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 14707-14712.
88. Huo TI, Wang XW, Forgues M, et al. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene 2001; 20: 3620-3628.
89. Gottlob K, Fulco M, Levrero M, et al. The hepatitis B virus HBx protein inhibits caspase 3 activity. Journal of Biological Chemistry 1998; 273: 33347-33353.
90. Marusawa H, Matsuzawa S, Welsh K, et al. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO Journal 2003; 22: 2729-2740.
91. Lee YI, Hwang JM, Im JH, et al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. Journal of Biological Chemistry 2004; 279: 15460-15471.
92. Waris G, Huh KW, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Molecular and Cellular Biology 2001; 21: 7721-7730.
93. Kim S, Kim HY, Lee S, et al. Hepatitis B virus x protein induces perinuclear mitochondrial clustering in microtubule- and Dynein-dependent manners. Journal of Virology 2007; 81: 1714-1726.
94. Ha HL, Yu DY. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN/Akt pathway. World Journal of Gastroenterology 2010; 16: 4932-4937.
95. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumour necrosis alpha. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 8744-8749.
96. Chirillo P, Pagano S, Natoli G, et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 8162-8167.
97. Wang WH, Hullinger RL, Andrisani OM. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. Journal of Biological Chemistry 2008; 283: 25455-25467.
98. Terradillos O, Pollicino T, Lecoeur H, et al. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 1998; 17: 2115-2123.
99. Madden CR, Finegold MJ, Slagle BL. Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. Journal of Virology 2000; 74: 5266-5272.
100. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. Journal of General Virology 2006; 87: 1439-1449.
101. Lara-Pezzi E, Majano PL, Gomez-Gonzalo M, et al. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Hepatology 1998; 28: 1013-1021.
102. Majano P, Lara-Pezzi E, Lopez-Cabrera M, et al. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation. Hepatology 2001; 34: 1218-1224.
103. Diehl AM. Cytokine regulation of liver injury and repair. Immunology Reviews 2000; 174: 160-171.
104. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annual Review of Immunology 2001; 19: 65-91.
105. Wei C, Ni C, Song T, et al. The hepatitis B virus X protein disrupts innate immunity by downregulation mitochondrial antiviral signalling protein. Journal of Immunology 2010; 185: 1158-1168.
106. Friedman SL. Mechanisms of hepatic fibrosis. Gastroenterology 2008; 134: 1655-1669.
107. Gutierrez-Reyes G, Gutierrez-Ruiz MC, Kershenobich D. Liver fibrosis and chronic viral hepatitis. Archives of Medical Research 2007; 38: 644-651.
108. Martin-Vilchez S, Sanz-Cameno P, Rodriguez-Munoz Y, et al. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008; 47: 1872-1883.
109. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular and Molecular Medicine 2006; 10: 76-99.
110. Chung TW, Lee YC, Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. The FASEB Journal 2004; 18: 1123-1125.
111. Feitelson MA, Reis HM, Tufan NL, et al. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Cancer Letters 2009; 286: 69-79.
112. Yoo YG, Cho S, Park S, et al. The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1alpha. FEBS Letters 2004; 577: 121-126.
113. Yoo YG, Oh SH, Park ES, et al. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. Journal of Biological Chemistry 2003; 278: 39076-39084.
114. Holotnakova T, Tylkova L, Takacova M, et al. Role of the HBx oncoprotein in carbonic anhydrase 9 induction. Journal of Medical Virology 2010; 82: 32-40.
115. Yoo YG, Na TY, Seo HW, et al. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008; 27: 3405-3413.
116. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2002; 2: 161-174.
117. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
118. Ou DP, Tao YM, Chang ZG, et al. Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally. Digestive and Liver Disease 2006; 38: 262-267.
119. Yu FL, Liu HJ, Lee JW, et al. Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3. Journal of Hepatology 2005; 42: 520-527.
120. Sanz-Cameno P, Martin-Vilchez S, Lara-Pezzi E, et al. Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein. American Journal of Pathology 2006; 169: 1215-1222.
121. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Letters 2007; 252: 157-170.
122. Ma NF, Lau SH, Hu L, et al. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clinical Cancer Research 2008; 14: 5061-5068.
123. Tu H, Bonura C, Giannini C, et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Research 2001; 61: 7803-7810.
124. Wang Y, Lau SH, Sham JS, et al. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis. Oncogene 2004; 23: 142-148.
125. Gottlob K, Pagano S, Levrero M, et al. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Research 1998; 58: 3566-3570.
126. Seifer M, Hohne M, Schaefer S, et al. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology 1991; 13(Suppl 4): S61-S65.
127. Kim YC, Song KS, Yoon G, et al. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene 2001; 20: 16-23.
128. Oishi N, Shilagardi K, Nakamoto Y, et al. Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells. Cancer Science 2007; 98: 1540-1548.
129. Oguey D, Dumenco LL, Pierce RH, et al. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Hepatology 1996; 24: 1024-1033.
130. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. Journal of Biological Chemistry 1998; 273: 381-385.
131. Schuster R, Gerlich WH, Schaefer S. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 2000; 19: 1173-1180.
132. Leenders MW, Nijkamp MW, Borel Rinkes IH. Mouse models in liver cancer research: a review of current literature. World Journal of Gastroenterology 2008; 14: 6915-6923.
133. Yu DY, Moon HB, Son JK, et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. Journal of Hepatology 1999 Jul; 31(1): 123-132.
134. Kim CM, Koike K, Saito I, et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317-320.
135. Koike K, Moriya K, Iino S, et al. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994; 19: 810-819.
136. Kurt Reifenberg, Petra Nusser, Jürgen Löhler, et al. Virus replication and virion export in X-deficient hepatitis B virus transgenic mice. Journal of General Virology 2002; 83: 991-996.
137. Lee TH, Finegold MJ, Shen RF, et al. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. Journal of Virology 1990 Dec; 64: 5939-5947.
138. Madden CR, Finegold MJ, Slagle BL. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. Journal of Virology 2001; 75: 3851-3858.
139. Madden CR, Finegold MJ, Slagle BL. Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. Journal of Virology 2002; 76: 11770-11774.
140. Terradillos O, Billet O, Renard CA, et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997; 14: 395-404.
141. Wang Y, Cui F, Lv Y, et al. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 2004; 39: 318-324.
142. Keng VW, Tschida BR, Bell JB, Largaespada DA. Modeling hepatitis B virus X-induced hepatocellular carcinoma in mice with the Sleeping Beauty transposon system. Hepatology 2011 Mar; 53: 781-790.